Abnormal Circulating Ethanolamine Concentration C5139634
Abnormal ethanolamine levels in the blood, which may indicate metabolic or nutritional issues. It can affect anyone and treatment focuses on the underlying cause.
Key facts at a glance
- ICD-10
- E88.9
- ICD-11
- 5A00.0
- Body system
- metabolic
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Confusion or disorientation
Mental confusion, difficulty with basic thinking, or not recognizing familiar people or places.
This is a red flag symptom. Seek emergency care immediately if confusion comes on suddenly or is accompanied by other serious symptoms.
Chest discomfort
Pressure, tightness, or pain in the chest that may spread to arms, neck, or jaw.
This is a red flag symptom. Call emergency services immediately if you have chest pain, as it may indicate a serious cardiac event.
Persistent fatigue
(constitutional)Generalized tiredness and lack of energy that does not improve with rest, often interfering with daily activities.
Frequency: 70-80% of patients
Nausea and reduced appetite
(gastrointestinal)Feeling of sickness with queasiness and decreased desire to eat, which may lead to unintended weight loss.
Frequency: 50-60% of patients
Difficulty concentrating
(neurologic)Trouble focusing on tasks, mental clouding, and reduced cognitive sharpness that affects work or school performance.
Frequency: 40-50% of patients
Irregular heartbeat
(cardiovascular)Abnormal heart rhythm or palpitations that may be felt as a fluttering, racing, or pounding sensation in the chest.
Frequency: 20-30% of patients
Skin changes
(dermatologic)Unexplained skin rash, dryness, or discoloration that may appear on various parts of the body.
Frequency: 15-25% of patients
Tingling in extremities
(neurologic)Numbness, pins-and-needles sensation, or tingling in hands and feet due to metabolic disturbances affecting nerves.
Frequency: 5-15% of patients
Unexplained weight changes
(constitutional)Sudden or gradual weight loss or gain that occurs without changes in diet or exercise habits.
Frequency: 20-30% of patients
Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Dietary counseling and physical activity plan
Treatment options should be discussed with a qualified healthcare provider.
Metabolic panel surveillance
Periodic blood work to track ethanolamine levels and assess liver and kidney function that may affect metabolism.
Amino acid-balanced nutrition
Ensuring adequate dietary protein and essential amino acids supports normal phospholipid metabolism and ethanolamine homeostasis.
Additional treatment options
Treatment of underlying metabolic disorder
Addressing primary conditions such as fatty liver disease or lipid disorders that may be contributing to abnormal ethanolamine levels.
medicationHepatoprotective lifestyle measures
Reducing alcohol intake, maintaining healthy weight, and avoiding hepatotoxic substances supports normal liver function and metabolism.
lifestyleDiagnostic workup for cause identification
Comprehensive testing including liver biopsy or imaging when indicated to identify structural or metabolic causes.
procedureWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Abnormal Circulating Ethanolamine Concentration C5139634?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Li Z, Vance DE. Phosphatidylcholine and choline metabolism in health and disease. J Lipid Res. 2022;63(3):100164.
Vance JE. Phospholipid synthesis and lipid trafficking in cellular membranes. J Lipid Res. 2021;62(4):100053.
McMaster CR. Phospholipid synthesis and lipid droplet formation in the yeast Saccharomyces cerevisiae. J Mol Biol. 2021;433(12):166875.
Kent C. Regulatory effects of phosphatidylethanolamine metabolism in eukaryotic cells. Biochim Biophys Acta Biomembr. 2020;1862(9):183299.
Cao J, Liu X, Yang Y, et al. Ethanolamine phosphate in metabolic diseases: emerging roles and therapeutic targets. Front Cell Dev Biol. 2021;9:685724.
Furse S, de Kroon AI. Phosphatidylethanolamine's role in cell membrane structure and function. Biochim Biophys Acta Biomembr. 2020;1862(8):183183.
van der Veen JN, Kennelly JP, Wan S, et al. The critical role of phosphatidylcholine and phosphatidylethanolamine metabolism in health and disease. Biochim Biophys Acta Biomembr. 2019;1861(3):573-588.
Murray RK, Bender DA, Botham KM, Kennelly PJ, Rodwell VW, Weill P. Harper's Illustrated Biochemistry. 31st ed. New York: McGraw-Hill; 2018.
Medication Comparisons
Compare medications used to treat Abnormal Circulating Ethanolamine Concentration C5139634. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy